Ann: Quarterly Activities Report & Appendix 4C - 31 December 2020, page-41

2.8m in group EBITDA for Dec Q I am assuming you're referring to? Yes, maybe DNA could make in the region of 3 to 5m on group level, but that is EBITDA not NPAT. Depends really on the operating cash flow, which EBITDA can be a bit of a proxy for, although operating cash flow was 2.1m above group EBITDA for the quarter, in fact more because about 1m in finance costs was paid as well. Receipts from customers 3m above reported revenue, so not entirely sure what went on there, seems like it might be an unwinding of working capital via customer payments from a previous period. Next quarter might not be as rosy, still looking a lot better than a year ago.